Samer O. Abdul‐Hay

795 total citations
18 papers, 535 citations indexed

About

Samer O. Abdul‐Hay is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Samer O. Abdul‐Hay has authored 18 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Physiology and 7 papers in Pharmacology. Recurrent topics in Samer O. Abdul‐Hay's work include Alzheimer's disease research and treatments (10 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Samer O. Abdul‐Hay is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). Samer O. Abdul‐Hay collaborates with scholars based in United States, China and Germany. Samer O. Abdul‐Hay's co-authors include Malcolm A. Leissring, Dongcheul Kang, Gregory R. J. Thatcher, Lilin Li, Abdul H. Fauq, Huali Wang, Paul Säftig, Dennis W. Dickson, Terrone L. Rosenberry and Caitlin N. Suire and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Samer O. Abdul‐Hay

18 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samer O. Abdul‐Hay United States 14 260 238 91 70 60 18 535
Jean‐François Blain Canada 12 314 1.2× 226 0.9× 105 1.2× 162 2.3× 99 1.6× 23 602
Jung Hyun Boo South Korea 13 374 1.4× 448 1.9× 123 1.4× 75 1.1× 56 0.9× 14 791
Eun Suk Song United States 13 267 1.0× 245 1.0× 45 0.5× 65 0.9× 33 0.6× 17 443
Hsiu‐Chiung Yang United States 14 208 0.8× 498 2.1× 95 1.0× 94 1.3× 68 1.1× 28 858
Inge Tomic Germany 10 387 1.5× 256 1.1× 77 0.8× 116 1.7× 51 0.8× 12 639
Mi-Hee Ko South Korea 11 326 1.3× 253 1.1× 60 0.7× 63 0.9× 31 0.5× 14 637
Juan A. Sánchez‐Arias Spain 17 168 0.6× 473 2.0× 222 2.4× 101 1.4× 38 0.6× 34 783
Yung-Feng Liao Taiwan 14 305 1.2× 275 1.2× 77 0.8× 31 0.4× 26 0.4× 20 673
Akira Gomori Japan 17 233 0.9× 308 1.3× 56 0.6× 48 0.7× 21 0.3× 25 1.1k
Amy G. Wong United States 11 436 1.7× 365 1.5× 116 1.3× 113 1.6× 27 0.5× 13 739

Countries citing papers authored by Samer O. Abdul‐Hay

Since Specialization
Citations

This map shows the geographic impact of Samer O. Abdul‐Hay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samer O. Abdul‐Hay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samer O. Abdul‐Hay more than expected).

Fields of papers citing papers by Samer O. Abdul‐Hay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samer O. Abdul‐Hay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samer O. Abdul‐Hay. The network helps show where Samer O. Abdul‐Hay may publish in the future.

Co-authorship network of co-authors of Samer O. Abdul‐Hay

This figure shows the co-authorship network connecting the top 25 collaborators of Samer O. Abdul‐Hay. A scholar is included among the top collaborators of Samer O. Abdul‐Hay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samer O. Abdul‐Hay. Samer O. Abdul‐Hay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Abdul‐Hay, Samer O., Dongcheul Kang, Dennis W. Dickson, et al.. (2024). Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis. Alzheimer s Research & Therapy. 16(1). 70–70. 11 indexed citations
2.
Suire, Caitlin N., Samer O. Abdul‐Hay, Dongcheul Kang, et al.. (2020). Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40. Alzheimer s Research & Therapy. 12(1). 80–80. 50 indexed citations
3.
Li, Huajie, Haihao Zhu, Mkaya Mwamburi, et al.. (2015). Age and Its Association with Low Insulin and High Amyloid-β Peptides in Blood. Journal of Alzheimer s Disease. 49(1). 129–137. 14 indexed citations
4.
Abdul‐Hay, Samer O., Thomas D. Bannister, Hui Wang, et al.. (2015). Selective Targeting of Extracellular Insulin-Degrading Enzyme by Quasi-Irreversible Thiol-Modifying Inhibitors. ACS Chemical Biology. 10(12). 2716–2724. 23 indexed citations
5.
Abdul‐Hay, Samer O., et al.. (2013). Optimization of Peptide Hydroxamate Inhibitors of Insulin-Degrading Enzyme Reveals Marked Substrate-Selectivity. Journal of Medicinal Chemistry. 56(6). 2246–2255. 44 indexed citations
6.
Abdul‐Hay, Samer O., et al.. (2012). Identification of BACE2 as an avid ß-amyloid-degrading protease. Molecular Neurodegeneration. 7(1). 46–46. 50 indexed citations
7.
Liu, Zhiheng, Haihao Zhu, Kathryn Walsh, et al.. (2012). Characterization of Insulin Degrading Enzyme and Other Amyloid-β Degrading Proteases in Human Serum: A Role in Alzheimer's Disease?. Journal of Alzheimer s Disease. 29(2). 329–340. 26 indexed citations
8.
Dunlap, Tareisha L., et al.. (2012). Quinone-Induced Activation of Keap1/Nrf2 Signaling by Aspirin Prodrugs Masquerading as Nitric Oxide. Chemical Research in Toxicology. 25(12). 2725–2736. 19 indexed citations
9.
Abdul‐Hay, Samer O., Isaac T. Schiefer, R. Esala P. Chandrasena, et al.. (2011). NO-SSRIs: Nitric Oxide Chimera Drugs Incorporating a Selective Serotonin Reuptake Inhibitor. ACS Medicinal Chemistry Letters. 2(9). 656–661. 13 indexed citations
10.
Abdul‐Hay, Samer O., et al.. (2011). Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin Tolerance. PLoS ONE. 6(6). e20818–e20818. 88 indexed citations
11.
Abdul‐Hay, Samer O., et al.. (2011). O1‐05‐06: Functional cDNA screening identifies BACE‐2 as a principal beta‐amyloid degrading protease. Alzheimer s & Dementia. 7(4S_Part_3). 2 indexed citations
12.
Schiefer, Isaac T., et al.. (2011). Inhibition of Amyloidogenesis by Nonsteroidal Anti-inflammatory Drugs and Their Hybrid Nitrates. Journal of Medicinal Chemistry. 54(7). 2293–2306. 27 indexed citations
13.
Leissring, Malcolm A., E. Malito, Lael Reinstatler, et al.. (2010). Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin. PLoS ONE. 5(5). e10504–e10504. 82 indexed citations
14.
Abdul‐Hay, Samer O., et al.. (2009). Selective modulation of amyloid‐β peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Aβ levels. Journal of Neurochemistry. 111(3). 683–695. 15 indexed citations
15.
Abdul‐Hay, Samer O., et al.. (2009). NO‐flurbiprofen reduces amyloid‐β, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade. Journal of Neurochemistry. 111(3). 766–776. 20 indexed citations
16.
Abdul‐Hay, Samer O., Johann Sohn, R. Esala P. Chandrasena, et al.. (2008). Anti-Inflammatory, Antiproliferative, and Cytoprotective Activity of NO Chimera Nitrates of Use in Cancer Chemoprevention. Molecular Pharmacology. 74(5). 1381–1391. 14 indexed citations
17.
Chirapu, Srinivas Reddy, Xin Cheng, David C. Lankin, et al.. (2008). Molecular modeling, synthesis, and activity studies of novel biaryl and fused-ring BACE1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(1). 264–274. 12 indexed citations
18.
Dunlap, Tareisha L., Samer O. Abdul‐Hay, R. Esala P. Chandrasena, et al.. (2008). Nitrates and NO-NSAIDs in cancer chemoprevention and therapy: In vitro evidence querying the NO donor functionality. Nitric Oxide. 19(2). 115–124. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐François Blain Breakdown of academic impact, for papers by Jung Hyun Boo Breakdown of academic impact, for papers by Eun Suk Song Breakdown of academic impact, for papers by Hsiu‐Chiung Yang Breakdown of academic impact, for papers by Inge Tomic Breakdown of academic impact, for papers by Mi-Hee Ko Breakdown of academic impact, for papers by Juan A. Sánchez‐Arias Breakdown of academic impact, for papers by Yung-Feng Liao Breakdown of academic impact, for papers by Akira Gomori Breakdown of academic impact, for papers by Amy G. Wong
Rankless by CCL
2026